|
|
| | CARBAMOYL-DL-ASPARTIC ACID Basic information |
| Product Name: | CARBAMOYL-DL-ASPARTIC ACID | | Synonyms: | N-CARBAMYL-DL-ASP;N-CARBAMYL-DL-ASPARTIC ACID;N-CARBAMOYL-DL-ASPARTIC ACID;UREIDOSUCCINIC ACID;CARBAMYL-DL-ASPARTIC ACID;CARBAMOYL-DL-ASPARTIC ACID;DL-UREIDOSUCCINIC ACID;N-Carbamyl-DL-aspartic acid Ureidosuccinic acid | | CAS: | 923-37-5 | | MF: | C5H8N2O5 | | MW: | 176.13 | | EINECS: | 213-096-6 | | Product Categories: | amino;Miscellaneous Biochemicals | | Mol File: | 923-37-5.mol |  |
| | CARBAMOYL-DL-ASPARTIC ACID Chemical Properties |
| Melting point | ~175 °C (dec.) | | Boiling point | 307.71°C (rough estimate) | | density | 1.6018 (rough estimate) | | refractive index | 1.4472 (estimate) | | storage temp. | Sealed in dry,2-8°C | | solubility | Aqueous Acid (Slightly), DMSO (Slightly) | | form | Solid | | pka | 3.65±0.23(Predicted) | | color | White to Off-White | | Water Solubility | Soluble in hot water. | | BRN | 1726861 | | CAS DataBase Reference | 923-37-5(CAS DataBase Reference) |
| Safety Statements | 24/25 | | WGK Germany | 3 | | HS Code | 2922498590 |
| | CARBAMOYL-DL-ASPARTIC ACID Usage And Synthesis |
| Chemical Properties | white fine crystalline powder | | Uses | N-Carbamoyl-DL-aspartic acid, is a useful biochemical for proteomics research. It is also used as a carbamate derivative which serves as an intermediate in pyrimidine biosynthesis. | | Definition | ChEBI: An N-carbamoylamino acid that is aspartic acid with one of its amino hydrogens replaced by a carbamoyl group. | | Biological Activity | Metabolite of pyrimidine biosynthesis, alanine, aspartate and glutamate metabolism. | | in vivo | N-?Carbamoyl-?DL-?aspartic acid (350 mg/kg; subcutaneous injection; twice daily; for 18 days) shows antitumor activity in a murine Lewis lung carcinoma model[2]. | Animal Model: | Male B6D2Fl mice were subcutaneously injected Lewis lung carcinoma cells[2] | | Dosage: | 350 mg/kg | | Administration: | Subcutaneous injection; twice daily; for 18 days | | Result: | Inhibited antitumor activity and toxicity induced by N-phosphonacetyl-L-aspartate (PALA). |
|
| | CARBAMOYL-DL-ASPARTIC ACID Preparation Products And Raw materials |
|